FrancophonIA/ELRC3.0 huggingface dataset:
English: ANNEX II A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. STATEMENT OF THE MRLs D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Slovenian: Ime in naslov proizvajalca (proizvajalcev) biološke (bioloških) učinkovine (učinkovin) Zoetis Manufacturing & Research Spain, S.L.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Bottle of 20 ml (BTV-1 for sheep and cattle; BTV-8 for sheep and cattle)
Slovenian: Plastenka po 20 ml (BTV-1 za ovce in govedo; BTV-8 za ovce in govedo) IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI
English: Symptoms are expected to improve within 1 to 2 weeks.
Slovenian: Izboljšanje simptomov se pričakuje v enem do dveh tednih.
English: In case there is no improvement within 4 weeks, the veterinarian should re-evaluate treatment.
Slovenian: Če po štirih tednih ni izboljšanja, naj veterinar zdravljenje ponovno pretehta.
English: Reconcile fluoxetine
Slovenian: Reconcile fluoksetin
English: The European Commission granted a marketing authorisation valid throughout the EU for Reconcile on 8 July 2008.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Reconcile, veljavno po vsej Evropski uniji, izdala 8. julija 2008.
English: Fluoxetine is an antidepressant.
Slovenian: Fluoksetin je antidepresiv.
English: It is not intended to provide practical advice on how to use Reconcile.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
English: This is a summary of the European public assessment report (EPAR) for Reconcile.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Reconcile.
English: EMA/CVMP/214641/2008 EMEA/V/C/000133
Slovenian: EMEA/CVMP/214641/2008 EMEA/V/C/000133
English: Reconcile is available as tablets (8, 16, 32 and 64 mg) and can only be obtained with a prescription.
Slovenian: Zdravilo Reconcile je na voljo v obliki tablet (8, 16, 32 in 64 mg), njegovo predpisovanje in izdaja pa je le na recept.
English: The study showed that Reconcile was as effective as clomipramine.
Slovenian: Študija je pokazala, da je bilo zdravilo Reconcile enako učinkovito kot klomipramin.
English: What is Reconcile and what is it used for?
Slovenian: Kaj je zdravilo Reconcile in za kaj se uporablja?
English: Reconcile should only be given in combination with behavioural therapy.
Slovenian: Zdravilo Reconcile se lahko daje samo v kombinaciji z vedenjsko terapijo.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Reconcile's benefits are greater than its risks and recommended that it be approved for use in the EU.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Reconcile večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
English: If the product is accidentally swallowed by a person, the advice of a doctor should be sought immediately.
Slovenian: Če zdravilo nenamerno zaužije človek, se je treba nemudoma posvetovati z zdravnikom.
English: The full EPAR for Reconcile can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila Reconcile je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: Fluoxetine works by increasing the levels of the neurotransmitter serotonin in the central nervous system.
Slovenian: Deluje tako, da poveča ravni živčnega prenašalca serotonina v osrednjem živčnem sistemu.
English: What benefits of Reconcile have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Reconcile izkazalo v študijah?
English: Since low levels of serotonin can be linked to depression and anxiety, increasing them can help dogs feel calmer so improving the behaviour in dogs with separation-related problems.
Slovenian: Nizke ravni serotonina so lahko povezane z depresijo in anksioznostjo, zato lahko njihovo zvišanje psom pomaga, da se umirijo, s čimer se izboljša njihovo vedenje, nastalo zaradi težav, povezanih z ločitvijo.
English: What are the risks associated with Reconcile?
Slovenian: Kakšna tveganja so povezana z zdravilom Reconcile?
English: Reconcile must not be given to dogs weighing less than 4 kg or to dogs with epilepsy or a history of fits.
Slovenian: Zdravilo Reconcile se ne sme dajati psom, ki tehtajo manj od 4 kg, ali psom z epilepsijo oziroma napadi v anamnezi.
English: Other information about Reconcile?
Slovenian: Druge informacije o zdravilu Reconcile?
English: The main measure of effectiveness was the change in each of the nine different behaviours recognised as characteristic indicators of separation anxiety in dogs.
Slovenian: Glavno merilo učinkovitosti je bila sprememba v vsakem od devetih različnih vedenjih, ki so značilne za anksioznost, povezano z ločitvijo, pri psih.
English: Such problems may include destruction of property, excessive barking or howling and inappropriate defecation and urination in the home.
Slovenian: Te motnje lahko obsegajo uničevanje lastnine, pretirano lajanje ali zavijanje in neprimerno odvajanje blata ali vode v notranjih prostorih.
English: It must also not be used in dogs which are hypersensitive (allergic) to the active substance, any other ingredients or medicines in the same class as fluoxetine (serotonin-reuptake inhibitors).
Slovenian: Prav tako se ne sme uporabljati pri psih, ki so preobčutljivi za (alergični na) zdravilno učinkovino, katero koli drugo sestavino zdravila ali zdravila iz istega razreda, kot je fluoksetin (zaviralci ponovnega privzema serotonina).
English: Why is Reconcile approved?
Slovenian: Zakaj je bilo zdravilo Reconcile odobreno?
English: The most common side effects with Reconcile (which may affect more than 1 in 10 dogs) are loss of appetite and lethargy (lack of energy).
Slovenian: Najpogostejši neželeni učinki zdravila Reconcile (ki lahko prizadenejo več kot 1 psa od 10) so izguba teka in letargija (pomanjkanje energije).
English: After 8 weeks of treatment, two separation anxiety behaviours were significantly improved in the Reconcile group (inappropriate defecation and destructive behaviour).
Slovenian: Po osmih tednih zdravljenja so v skupini, ki je prejemala Reconcile, opazili občutno izboljšanje dveh vzorcev anksioznega vedenja, povezanega z ločitvijo (neprimerno odvajanje blata in uničevalno vedenje).
English: For the full list of all side effects and restrictions reported with Reconcile, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov in omejitev, o katerih so poročali pri uporabi zdravila Reconcile, glejte navodilo za uporabo.
English: Other common side effects with Reconcile (which may affect up to 1 in 10 dogs) are urinary problems (inflammation of the bladder, lack of control in passing urine, inability to completely empty the bladder, and pain and difficulty in passing urine), and lack of coordination and disorientation.
Slovenian: Drugi pogosti neželeni učinki zdravila Reconcile (ki lahko prizadenejo največ 1 psa od 10) so težave pri uriniranju (vnetje mehurja, pomanjkljiv nadzor nad uhajanjem urina, nesposobnost popolne izpraznitve mehurja ter bolečina in težavno uriniranje), pa tudi zmanjšana koordinacija gibov in izguba orientacije.
English: All dogs received behavioural therapy and were treated either with Reconcile or with clomipramine (another medicine used to treat dogs with separation-related disorders).
Slovenian: Vsi psi so prejemali vedenjsko terapijo in bodisi zdravilo Reconcile ali klomipramin (drugo vrsto zdravila, ki se uporablja za zdravljenje psov z vedenjskimi težavami, povezanimi z ločitvijo).
English: A field study was conducted in a large number of dogs that were treated for separation anxiety in two European countries.
Slovenian: V dveh evropskih državah je bila opravljena terenska študija z velikim številom psov, ki so bili zdravljeni zaradi anksioznosti, povezane z ločitvijo.
English: Reconcile is a veterinary medicine used as an aid to treat dogs with behavioural problems caused by separation from their owners or homes or from other dogs (separation anxiety).
Slovenian: Reconcile je zdravilo za uporabo v veterinarski medicini, ki se uporablja kot dodatek pri zdravljenju psov z vedenjskimi težavami, nastalimi zaradi ločitve od lastnika, doma ali drugih psov.
English: How is Reconcile used?
Slovenian: Kako se zdravilo Reconcile uporablja?
English: It contains the active substance fluoxetine.
Slovenian: Vsebuje zdravilno učinkovino fluoksetin.
English: For practical information about using Reconcile, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Reconcile naj lastniki ali skrbniki živali preberejo navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom.
English: For more information about treatment with Reconcile, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Reconcile naj lastniki ali skrbniki živali preberejo navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom.
English: The tablets are given once a day.
Slovenian: Izbrana jakost tablete je odvisna od telesne mase psa. Tablete se dajejo enkrat na dan.
English: How does Reconcile work?
Slovenian: Kako zdravilo Reconcile deluje?
English: The main measure of effectiveness was based on improvements in any of these four symptoms during the first 24 weeks of treatment.
Slovenian: Glavno merilo učinkovitosti je temeljilo na izboljšanju katerega koli izmed teh simptomov v prvih 24 tednih zdravljenja.
English: The company requested a re-examination of the initial opinion.
Slovenian: Družba je zahtevala ponovno preučitev prvotnega mnenja.
English: those involved in stimulating the cells to grow and divide.
Slovenian: tistimi, ki sodelujejo pri stimulaciji rasti in delitve celic.
English: In addition, major changes were made to the study design while the study was ongoing, which made the results difficult to interpret.
Slovenian: Poleg tega so v času izvajanja študije precej spremenili zasnovo študije, zato je rezultate težko razlagati.
English: The CHMP refusal was confirmed after re-examination.
Slovenian: Zavrnitev odbora CHMP je bila po ponovnem pregledu potrjena.
English: The CHMP was concerned about the reliability of the study results because a routine GCP (good clinical practice) inspection at the study sites revealed serious failings in the way the study had been conducted.
Slovenian: Odbor CHMP je imel zadržke glede zanesljivosti rezultatov študije, saj je rutinski inšpekcijski pregled dobre klinične prakse na lokacijah klinične študije pokazal resne pomanjkljivosti v načinu izvedbe študije.
English: After considering the grounds for this request, the CHMP re-examined the opinion, and confirmed the refusal of the marketing authorisation on 14 September 2017.
Slovenian: Po proučitvi razlogov za to zahtevo je odbor CHMP ponovno pregledal mnenje in dne 14. septembra 2017 potrdil zavrnitev vloge za dovoljenje za promet.
English: Refusal of the marketing authorisation for Masipro (masitinib) EMA/599464/2017
Slovenian: Zavrnitev vloge za dovoljenje za promet z zdravilom Masipro (masitinib) EMA/599464/2017
English: By blocking these enzymes, Masipro is thought to help slow down the growth of the mast cells.
Slovenian: Z zaviranjem teh encimov naj bi zdravilo Masipro pomagalo upočasniti rast mastocitov.
English: This means that it blocks enzymes known as tyrosine kinases, which can be found in some receptors in mast cells including
Slovenian: To pomeni, da zavira encime, znane kot tirozin-kinaze, ki se nahajajo v nekaterih receptorjih na mastocitih, vključno s
English: The applicant presented data from a main study involving 135 patients with systemic mastocytosis who had severe symptoms including at least one of the following four: itching, hot flushes, depression and tiredness.
Slovenian: Predlagatelj je predložil podatke glavne študije, ki je vključevala 135 bolnikov s sistemsko mastocitozo, ki so imeli hude simptome, vključno z vsaj enim izmed naslednjih štirih: srbenje, vročinski oblivi, depresija in utrujenost.
English: Finally, data on the safety of the medicine were limited and there were concerns regarding the medicine's side effects, including neutropenia (low levels of white blood cells) and harmful effects on the skin and liver, which were of relevance particularly because the medicine was to be used long term.
Slovenian: Tudi podatki o varnosti zdravila so bili omejeni in obstajali so pomisleki o neželenih učinkih zdravila, vključno z nevtropenijo (nizkim številom belih krvnih celic) in škodljivimi učinki na kožo in jetra, kar je bilo pomembno predvsem zato, ker naj bi se zdravilo uporabljalo dolgoročno.
English: Masipro was expected to be used to treat adults with systemic mastocytosis, a disease in which there are too many mast cells (a type of white blood cell) in the skin, bones and various body organs, causing symptoms such as itchy skin, hot flushes, palpitations, fainting, bone pain, tiredness, vomiting, diarrhoea and depression.
Slovenian: Zdravilo Masipro naj bi se uporabljalo za zdravljenje odraslih s sistemsko mastocitozo, boleznijo, pri katerih je v koži, kosteh in različnih telesnih organih preveč mastocitov (vrste belih krvnih celic), ki povzročajo simptome, kot so srbeča koža, navali vročine, palpitacije, omedlevica, bolečine v kosteh, utrujenost, bruhanje, driska in depresija.
English: How does Masipro work?
Slovenian: Kako zdravilo Masipro deluje?
English: Refusal of the marketing authorisation for Masipro (masitinib)
Slovenian: Zavrnitev vloge za dovoljenje za promet z zdravilom Masipro (masitinib)
English: On 18 May 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion, recommending the refusal of the marketing authorisation for the medicinal product Masipro, intended for the treatment of systemic mastocytosis.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je v svojem negativnem mnenju z dne 18. maja 2017 priporočil zavrnitev vloge za dovoljenje za promet z zdravilom Masipro, namenjenim zdravljenju sistemske mastocitoze.
English: What was Masipro expected to be used for?
Slovenian: Za kaj naj bi se zdravilo Masipro uporabljalo?
English: In the study, Masipro was compared with placebo (a dummy treatment).
Slovenian: V študiji so zdravilo Masipro primerjali s placebom (zdravilom brez zdravilne učinkovine).
English: Masipro was designated an ‘orphan medicine' (a medicine to be used in rare diseases) on 16 November 2004 for mastocytosis.
Slovenian: Zdravilo Masipro je bilo dne 16. novembra 2004 določeno kot „zdravilo sirota“ (zdravilo za zdravljenje redkih bolezni) za zdravljenje mastocitoze.
English: Therefore, the CHMP was of the opinion that the benefits of Masipro did not outweigh its risks and recommended that it be refused marketing authorisation.
Slovenian: Posledično je odbor CHMP tedaj menil, da koristi zdravila Masipro ne odtehtajo z njim povezanih tveganj, in priporočil, da se dovoljenje za promet z njim zavrne.
English: Masipro is a medicine that contains the active substance masitinib.
Slovenian: Masipro je zdravilo, ki vsebuje zdravilno učinkovino masitinib.
English: The company informed the CHMP that there are no consequences for patients in clinical trials or compassionate use programmes.
Slovenian: Družba je obvestila odbor CHMP, da zavrnitev nima posledic za bolnike, ki so vključeni v klinična preizkušanja ali programe sočutne uporabe.
English: The active substance in Masipro, masitinib, is a tyrosine kinase inhibitor.
Slovenian: Zdravilna učinkovina v zdravilu Masipro, masitinib, je zaviralec tirozin-kinaze.
English: The company that applied for authorisation is AB Science.
Slovenian: Vlogo za pridobitev dovoljenja za promet z zdravilom je predložila družba AB Science.
English: What is Masipro?
Slovenian: Kaj je zdravilo Masipro?
English: A/equine-2/South Africa/4/03 strain 50 AU/ml A/equine-2/Newmarket/2/93 strain
Slovenian: A/konjski-2/Južna Afrika/4/03 50 AU/ml A/konjski-2/ Newmarket/2/93 50 AU/ml
English: Horse Intramuscular use Vial (type I glass) closed with a halogenobutyl rubber stopper and aluminium cap.
Slovenian: Intramuskularno Viala (steklo tipa I) zaprta z zamaškom iz halogenobutilne gume in aluminijasto zaporko
English: --1 Equine influenza virus strains:
Slovenian: --1 Seva virusa influence konj:
English: MA (EU) number Invented name
Slovenian: EU številka Izmišljeno ime Jakost Farmacevtska oblika
English: 1 dose 10 glass vials
Slovenian: 1 odmerek 10 steklenih vi Nič dni
English: 1 dose 1 pre-filled syringe
Slovenian: 1 odmerek 1 napolnjena brizga
English: They involved over 5,000 people from 4 years of age.
Slovenian: Vključevali sta 5 000 ljudi, starejših od štirih let.
English: Further information on Flucelvax Tetra can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/Flucelvax-tetra
Slovenian: Nadaljnje informacije o zdravilu Flucelvax Tetra so na voljo na spletni strani agencije: ema.europa.eu/medicines/human/EPAR/Flucelvax-tetra
English: Each year, the World Health Organization (WHO) makes recommendations on which flu strains should be included in vaccines for the upcoming flu season in the northern hemisphere.
Slovenian: Svetovna zdravstvena organizacija (SZO) vsako leto pripravi priporočila o tem, kateri sevi gripe naj se vključijo v cepiva za naslednjo sezono gripe na severni polobli.
English: The recommended dose is one single injection into a muscle (0.5 ml), preferably in the upper arm.
Slovenian: Priporočeni odmerek je enkratna injekcija v mišico (0,5 ml), po možnosti v nadlaket.
English: The European Medicines Agency therefore decided that Flucelvax Tetra's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zato zaključila, da so koristi zdravila Flucelvax Tetra večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: The composition of Flucelvax Tetra will be updated annually according to WHO and EU recommendations.
Slovenian: Sestava cepiva Flucelvax Tetra bo vsako leto posodobljena v skladu s priporočili organizacije Svetovne zdravstvene organizacije in Evropske unije.
English: The studies assessed the ability of the vaccines to stimulate an immune response against influenza, by measuring the production of protective antibodies.
Slovenian: V študijah so ocenili sposobnost cepiv za sprožanje imunskega odziva proti gripi, tako da so merili tvorbo zaščitnih protiteles.
English: The most common side effects with Flucelvax Tetra (which may affect more than 1 in 10 people) are pain at the injection site, reddening of the skin and hardening at the injection site, headache, tiredness and muscle pain.
Slovenian: Najpogostejši neželeni učinki zdravila Flucelvax Tetra (ki lahko prizadenejo več kot 1 osebo od 10) so bolečina, pordelost in otrdelost kože na mestu injiciranja, glavobol, utrujenost in bolečine v mišicah.
English: What measures are being taken to ensure the safe and effective use of Flucelvax Tetra?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Flucelvax Tetra?
English: Side effects reported with Flucelvax Tetra are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Flucelvax Tetra, se skrbno ovrednotijo in po potrebi sprejmejo ukrepi za zaščito bolnikov.
English: The immune system will then be able to respond more quickly when it is exposed to the virus again.
Slovenian: Ob ponovni izpostavitvi virusom se bo imunski sistem lahko hitreje odzval nanje.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Flucelvax Tetra have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in varnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Flucelvax Tetra upoštevati zdravstveni delavci in bolniki, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za njegovo uporabo.
English: For more information about using Flucelvax Tetra, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Flucelvax Tetra glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: As for all medicines, data on the use of Flucelvax Tetra are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Flucelvax Tetra stalno spremljajo.
English: Flucelvax Tetra was compared with two comparator vaccines in 2 main studies.
Slovenian: Zdravilo Flucelvax Tetra so primerjali z dvema primerjalnima cepivoma v dveh glavnih študijah.
English: Flucelvax Tetra is a vaccine used to protect adults and children from 9 years of age against influenza (flu).
Slovenian: Zdravilo Flucelvax Tetra je cepivo, ki se uporablja za zaščito odraslih in otrok od 9. leta starosti proti influenci (gripi).
English: The inclusion of two influenza B strains in Flucelvax Tetra can provide a broader protection against influenza B. In terms of safety, side effects with Flucelvax Tetra are similar to those observed with vaccines containing three influenza strains and are mostly mild to moderate in severity.
Slovenian: Vključitev dveh sevov gripe B v zdravilo Flucelvax Tetra lahko zagotovi večjo zaščito proti gripi B. Z vidika varnosti so neželeni učinki zdravila Flucelvax Tetra podobni tistim, opaženim pri cepivih, ki vsebujejo tri seve virusa gripe in so večinoma blagi ali zmerni.
English: Flucelvax Tetra contains proteins from four different inactivated influenza A and B virus strains (type A-H1N1, type A-H3N2 and two type B strains), chosen based on the official recommendation for the annual flu season.
Slovenian: Zdravilo Flucelvax Tetra vsebuje beljakovine iz štirih različnih inaktiviranih sevov virusa gripe A in B (tip A-H1N1, tip A-H3N2 in dva seva virusa gripe B) na podlagi uradnega priporočila za vsakoletno sezono gripe.
English: Influenza is mainly caused by two kinds of influenza virus, known as influenza A and B. Each of these circulate as different strains and subtypes, which change over time.
Slovenian: Gripo običajno povzročata dve vrsti virusa, tj. virus gripe A in virus gripe B. Vsak od njiju kroži v obliki različnih sevov in podtipov, ki se sčasoma spreminjajo.
English: Results showed that Flucelvax Tetra lead to similar levels of protective antibodies as the comparator vaccines in people from 9 years of age.
Slovenian: Rezultati so pokazali, da zdravilo Flucelvax Tetra doseže podobne zaščitne ravni protiteles kot primerjalna cepiva pri ljudeh, starejših od devetih let.
English: Other information about Flucelvax Tetra
Slovenian: Druge informacije o zdravilu Flucelvax Tetra
English: An overview of Flucelvax Tetra and why it is authorised in the EU
Slovenian: Pregled zdravila Flucelvax Tetra in zakaj je odobreno v EU
English: Flucelvax Tetra is available as a suspension for injection in a pre-filled syringe.
Slovenian: Zdravilo Flucelvax Tetra je na voljo kot suspenzija za injiciranje v napolnjeni injekcijski brizgi.
English: The vaccine can only be obtained with a prescription and should be used according to official recommendations.
Slovenian: Predpisovanje in izdaja zdravila Flucelvax Tetra je le na recept, uporabljati pa se mora v skladu z uradnimi priporočili.
English: Why is Flucelvax Tetra authorised in the EU?
Slovenian: Zakaj je bilo zdravilo Flucelvax Tetra odobreno v EU?
English: The other vaccine is based on Optaflu but contains the other B strain of Flucelvax Tetra.
Slovenian: Drugo cepivo temelji na zdravilu Optaflu, a vsebuje drugi sev B, ki se nahaja v zdravilu Flucelvax Tetra.
English: When a person is given the vaccine, the immune system recognises the virus proteins as ‘foreign' and makes defences against them.
Slovenian: Ko oseba prejme cepivo, imunski sistem prepozna delce virusa kot tujke in proti njim razvije protitelesa.